NORMAL SITUATION

QbD Clinical

Export PDF

Company — Normal situation.

Financial year 2023 · Closed on 31/12/2023

Net result130,9 k €-88,1 %over 1 year
Gross margin6,7 M €+11,9 %over 1 year
Equity1,9 M €+7,6 %over 1 year
Workforce63,5 ETP+16,3 %over 1 year

Identity

Source · BCE/KBO

QbD Clinical is a company registered in Belgium. It employs on average 63,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0837.988.839
Legal form
Public limited company
Contributed capital
61 500,00 €
Latest accounts
31/12/2023
Average workforce
63,5 ETP
Joint committees (4)
  • 100
  • 1000
  • 200
  • 2000
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 12 filings

Trend over 10 financial years

20232022202120192018
Income statement
Gross margin6,7 M €6 M €6,3 M €2,1 M €1,4 M €
EBITDA452,7 k €1,6 M €1,5 M €707 k €226,2 k €
Operating result315,6 k €1,5 M €1,4 M €571,9 k €99,2 k €
Net result130,9 k €1,1 M €970,8 k €358,1 k €31,8 k €
Balance sheet
Equity1,9 M €1,7 M €1,4 M €1,1 M €759,1 k €
Total assets3,9 M €3,9 M €3 M €2,7 M €2,3 M €
Cash154,6 k €598,8 k €718 k €405,6 k €473,7 k €
Debts1,8 M €1,8 M €1,3 M €1,6 M €1,5 M €
Other
Workforce63,5 ETP54,6 ETP65,9 ETP18,3 ETP15,3 ETP

Board of directors

Source · NBB, accounts to 31/12/2023

1 active · 19 ended

Active mandates

QbD Growth

Director · since 12 mai 2023 · 0795.392.179

Represented by Bart VAN ACKER

Active

Ended mandates

Eelen Clinical Consulting

Director · since 31 mars 2022 · 0843.562.181

Represented by Jan EELEN

Ended
Pieters Clinical Consulting

Director · since 31 août 2020 · 0843.630.081

Represented by Magdaleen PIETERS

Ended
Quality for You

Chairman of the board of directors · since 31 août 2020 · 0598.934.517

Represented by Bart VAN ACKER

Ended
Tom Lokermans

Director · since 31 août 2020

Ended

Full financial information

Source · NBB
202320222021202020192018
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202301/01/202201/04/202001/04/201901/04/201801/04/2017
Closing of the financial year31/12/202331/12/202231/12/202131/03/202031/03/201931/03/2018
Length of the financial year12 months12 months21 months12 months12 months12 months
Filing date24/07/202428/07/202324/08/202203/09/202031/10/201931/10/2018
General meeting28/06/202430/06/202330/06/202221/08/202030/09/201921/09/2018
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202328/06/202424/07/2024DutchPDF
Abridged model31/12/202230/06/202328/07/2023DutchPDF
Abridged modelCorrection31/12/202130/06/202222/12/2022DutchPDF
Abridged model31/12/202130/06/202224/08/2022DutchPDF
Abridged model31/03/202021/08/202003/09/2020DutchPDF
Abridged model31/03/201930/09/201931/10/2019DutchPDF
Abridged model31/03/201821/09/201831/10/2018DutchPDF
Abridged model31/03/201715/09/201731/10/2017DutchPDF
Abridged model31/03/201616/09/201630/11/2016DutchPDF
Abridged model31/03/201518/09/201527/10/2015DutchPDF
Abridged model31/03/201419/09/201415/10/2014DutchPDF
Abridged model31/03/201320/09/201330/11/2013DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2023

1 active · 19 ended

Active mandates

QbD Growth

Director · since 12 mai 2023 · 0795.392.179

Represented by Bart VAN ACKER

Active

Ended mandates

Eelen Clinical Consulting

Director · since 31 mars 2022 · 0843.562.181

Represented by Jan EELEN

Ended
Pieters Clinical Consulting

Director · since 31 août 2020 · 0843.630.081

Represented by Magdaleen PIETERS

Ended
Quality for You

Chairman of the board of directors · since 31 août 2020 · 0598.934.517

Represented by Bart VAN ACKER

Ended
Tom Lokermans

Director · since 31 août 2020

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution09/10/2024
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring28/05/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates09/04/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/05/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/06/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/06/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares13/11/2020
    KAPITAAL - AANDELEN
    PDF
  • Mandates16/09/2020
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 2023130,9 k €↓
  2. 2022
    Annual accounts 20221,1 M €↑
  3. 2022
    Name changeQbD Clinical
  4. 2021
    Annual accounts 2021970,8 k €↑
  5. 2021
    Name changeTrium Clinical Consulting
  6. 2019
    Annual accounts 2019358,1 k €↑
  7. 2018
    Annual accounts 201831,8 k €↓
  8. 2017
    Annual accounts 2017225,4 k €↓
  9. 2016
    Annual accounts 2016272,1 k €↑
  10. 2015
    Annual accounts 2015142,1 k €↑
  11. 2014
    Annual accounts 201452,8 k €↑
  12. 2013
    Annual accounts 201332,9 k €